Our history
It determines us to be tireless in moving towards the FUTURE.
1998
ROXALL Group
established
2008
ROXALL Turkey
established
ROXALL Medizin expands its borders with its first subsidiary in Turkey.
2010
ROXALL Austria
established
ROXALL Medizin starts its expansion process in Austria, evolving into ROXALL Group.
2011
ROXALL Italy
established
A new ROXALL Group location in Italy for the commercialization of Immunotherapy products.
2017
ROXALL Spain
established
Acquisition of the allergy line in Bilbao, Spain (BIAL Aristegui). A solid foundation for growth today and in the future.
Immunotherapy research has been the main focus at this site for more than 70 years.
2021
Future expansion of
ROXALL
Expansion process outside Europe.
Key markets: Eurasia and LATAM.
2024
Positioning
We reaffirm our positioning at all our locations. Growth maintained in each of our subsidiaries.
Our goal: To maintain our flagship R&D and precision immunotherapy by looking to the FUTURE.
